tiprankstipranks
PolyPeptide Group AG (CH:PPGN)
:PPGN
Switzerland Market
PPGN
PolyPeptide Group AG
RESEARCH TOOLSreports
Want to see CH:PPGN full AI Analyst Report?

PolyPeptide Group AG (PPGN) Ratios

2 Followers

PolyPeptide Group AG Ratios

CH:PPGN's free cash flow for Q4 2025 was €0.23. For the 2025 fiscal year, CH:PPGN's free cash flow was decreased by € and operating cash flow was €0.09. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.74 1.74 1.69 1.85 2.62
Quick Ratio
 0.91 0.91 0.94 1.12 1.11
Cash Ratio
 0.40 0.40 0.35 0.54 0.39
Solvency Ratio
 0.03 0.03 0.03 -0.07 0.22
Operating Cash Flow Ratio
 0.41 0.42 0.46 0.21 0.06
Short-Term Operating Cash Flow Coverage
 13.89 14.06 2.92 0.88 4.98
Net Current Asset Value
€ -160.36M€ -160.36M€ -71.11M€ 18.74M€ 97.47M
Leverage Ratios
Debt-to-Assets Ratio
 0.16 0.16 0.12 0.16 0.04
Debt-to-Equity Ratio
 0.38 0.38 0.26 0.30 0.05
Debt-to-Capital Ratio
 0.28 0.28 0.21 0.23 0.05
Long-Term Debt-to-Capital Ratio
 0.24 0.24 0.10 0.11 0.02
Financial Leverage Ratio
 2.43 2.43 2.12 1.81 1.37
Debt Service Coverage Ratio
 0.97 1.86 0.57 -0.32 7.93
Interest Coverage Ratio
 0.22 0.40 -0.44 -5.08 3.67
Debt to Market Cap
 0.09 0.12 0.07 0.15 0.01
Interest Debt Per Share
 4.87 4.51 3.37 3.67 0.75
Net Debt to EBITDA
 1.25 1.26 0.91 -0.81 -0.46
Profitability Margins
Gross Profit Margin
16.44%16.41%11.59%1.49%18.50%
EBIT Margin
1.69%1.89%-1.27%-16.42%3.44%
EBITDA Margin
11.47%11.34%8.39%-6.91%12.71%
Operating Profit Margin
1.69%1.89%-2.17%-11.38%4.49%
Pretax Profit Margin
-5.14%-5.46%-5.36%-18.18%2.69%
Net Profit Margin
-5.43%-5.44%-5.78%-16.06%2.76%
Continuous Operations Profit Margin
-7.75%-5.44%-5.78%-16.06%2.76%
Net Income Per EBT
105.60%99.50%107.82%88.32%102.64%
EBT Per EBIT
-303.46%-288.87%246.40%159.71%60.02%
Return on Assets (ROA)
-2.56%-2.58%-2.59%-7.46%1.35%
Return on Equity (ROE)
-6.30%-6.26%-5.48%-13.49%1.84%
Return on Capital Employed (ROCE)
1.03%1.16%-1.31%-7.11%2.63%
Return on Invested Capital (ROIC)
1.02%1.14%-1.23%-5.77%2.65%
Return on Tangible Assets
-2.61%-2.63%-2.64%-7.65%1.39%
Earnings Yield
-1.62%-2.30%-1.97%-8.28%0.92%
Efficiency Ratios
Receivables Turnover
 4.43 4.45 3.93 4.07 5.72
Payables Turnover
 4.39 4.41 4.09 5.18 4.99
Inventory Turnover
 2.11 2.13 2.05 2.46 1.58
Fixed Asset Turnover
 0.85 0.85 0.87 0.99 0.95
Asset Turnover
 0.47 0.47 0.45 0.46 0.49
Working Capital Turnover Ratio
 2.98 2.88 2.39 2.10 1.47
Cash Conversion Cycle
 171.93 170.94 182.07 167.93 221.87
Days of Sales Outstanding
 82.39 81.93 92.96 89.75 63.84
Days of Inventory Outstanding
 172.77 171.75 178.40 148.62 231.24
Days of Payables Outstanding
 83.23 82.74 89.30 70.44 73.22
Operating Cycle
 255.16 253.68 271.37 238.37 295.09
Cash Flow Ratios
Operating Cash Flow Per Share
 2.34 2.36 2.71 1.11 0.17
Free Cash Flow Per Share
 -0.92 -0.92 0.07 -0.61 -2.11
CapEx Per Share
 3.25 3.29 2.64 1.72 2.28
Free Cash Flow to Operating Cash Flow
 -0.39 -0.39 0.03 -0.55 -12.75
Dividend Paid and CapEx Coverage Ratio
 0.72 0.72 1.03 0.64 0.06
Capital Expenditure Coverage Ratio
 0.72 0.72 1.03 0.64 0.07
Operating Cash Flow Coverage Ratio
 0.59 0.60 0.95 0.32 0.26
Operating Cash Flow to Sales Ratio
 0.20 0.20 0.26 0.11 0.02
Free Cash Flow Yield
-2.32%-3.29%0.24%-3.26%-8.26%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -63.60 -43.40 -50.85 -12.08 108.60
Price-to-Sales (P/S) Ratio
 3.45 2.36 2.94 1.94 3.00
Price-to-Book (P/B) Ratio
 3.95 2.72 2.78 1.63 2.00
Price-to-Free Cash Flow (P/FCF) Ratio
 -44.41 -30.38 409.26 -30.69 -12.11
Price-to-Operating Cash Flow Ratio
 17.46 11.85 11.13 17.03 154.48
Price-to-Earnings Growth (PEG) Ratio
 -1.65 -5.12 0.82 0.02 -1.30
Price-to-Fair Value
 3.95 2.72 2.78 1.63 2.00
Enterprise Value Multiple
 31.36 22.08 35.92 -28.86 23.16
Enterprise Value
 1.36B 980.74M 1.02B 639.29M 827.16M
EV to EBITDA
 30.43 22.08 35.92 -28.86 23.16
EV to Sales
 3.49 2.50 3.01 2.00 2.94
EV to Free Cash Flow
 -44.89 -32.22 419.89 -31.57 -11.88
EV to Operating Cash Flow
 17.65 12.57 11.42 17.52 151.50
Tangible Book Value Per Share
 9.89 9.89 10.39 11.07 12.30
Shareholders’ Equity Per Share
 10.31 10.31 10.85 11.57 12.78
Tax and Other Ratios
Effective Tax Rate
 -0.51 <0.01 -0.08 0.12 -0.03
Revenue Per Share
 11.81 11.88 10.28 9.73 8.52
Net Income Per Share
 -0.64 -0.65 -0.59 -1.56 0.24
Tax Burden
 1.06 1.00 1.08 0.88 1.03
Interest Burden
 -3.03 -2.89 4.22 1.11 0.78
Research & Development to Revenue
 <0.01 <0.01 <0.01 <0.01 <0.01
SG&A to Revenue
 0.14 0.14 0.06 0.05 0.12
Stock-Based Compensation to Revenue
 <0.01 0.00 <0.01 <0.01 <0.01
Income Quality
 -3.64 -3.66 -4.57 -0.71 0.70
Currency in EUR